Blood disorder startup Hemab Therapeutics raises $135M

Benny Sorensen remembers the days when, for patients with disorders that caused them to bleed with little provocation, "we had absolutely nothing to give them aside from old-fashioned blood transfusions." Now, he’s hoping to change that with a new startup. Read More

Read More